First iron resolution – Healthier people for lower costs

According to the WHO, over 3 billion people suffer from iron deficiency. Women of menstrual age and children are primarily affected. Medicine largely ignores iron deficiency in its early stage, Iron Deficiency Syndrome (IDS), because the common belief is that a deficiency in this element is only manifest as anemia (Iron Deficiency Anemia, IDA), i.e. in its late stage. Due to this misinterpretation, symptoms of IDS patients are repeatedly and unnecessarily clarified and ultimately incorrectly treated.

The SIHO proves that iron infusions are effective, safe and cost-efficient in iron deficiency patients (see Eurofer practical study). It encourages all physicians and their professional associations to adopt SIHO’s proven approach in order to detect iron deficiency patients at an early stage and to treat them correctly, in accordance with the goal: healthier people for lower costs.

Ethical reasons
As long as the iron deficiency syndrome IDS is not known to a broad medical profession, patients with iron deficiency symptoms are subjected to superfluous diagnostics and often treated purely symptomatically. The causes are not treated. As soon as an IDS has been diagnosed, however, causal therapy with iron infusions is required from an ethical point of view.

Scientific reasons
The scientific approach in the medical iron centres under the supervision of SIHO and the results obtained show the connections between iron deficiency and the symptoms caused by it even in the stage of IDS without anaemia. Further studies (e.g. at the University of Zurich) have confirmed this fact.

Historical reasons
The iron deficiency syndrome was first described at the Innsbruck University Hospital in 1957. In 1971 it was confirmed at the Charité Universitätsmedizin Berlin (textbook for doctors of all disciplines). Both universities confirm the significant advantage of iron infusions compared to oral iron therapy.

After the rediscovery of the IDS in Switzerland in 1998 and a seven-year development of the Swiss Iron System SIS, the network of Medical Iron Centres was founded in 2005.

The Swiss Iron Health Organisation SIHO was founded in 2007.

Health economic reasons
Most iron deficiency patients are cured by the necessary intravenous iron doses. Thanks to the individually dosed and controlled iron infusions, it is possible to implement the following credo: Healthier people for lower costs through

  • Intravenous Iron Gifts as First-Line Therapy
  • Avoidance of unnecessary clarifications and symptomatic treatments
  • Avoidance of false psychiatrisations
  • Avoidance of unnecessary work stoppages
  • Avoidance of unnecessary pensions

This iron resolution was signed in Binningen / Basel on 1 August 2015 by doctors from Switzerland, Germany and Russia.